Trials / Completed
CompletedNCT02025894
Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,032 (actual)
- Sponsor
- Institut de Cancérologie de la Loire · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-01-01
- Last updated
- 2017-03-07
Locations
27 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02025894. Inclusion in this directory is not an endorsement.